Table 1. Prognostic impact of FAM83D expression level in 18 possible pools corresponding to every combination of populations (nodal and ER status).
LN | ER | Event status | p-value | Hazard ratio | 95% CI | No patients | No events |
---|---|---|---|---|---|---|---|
Nm | Erm | AE | < 0.0001 | 1.34 | 1.26 - 1.43 | 2653 | 909 |
Nm | ER+ | MR | < 0.0001 | 1.56 | 1.41 - 1.71 | 1198 | 282 |
Nm | ERm | MR | < 0.0001 | 1.44 | 1.33 - 1.56 | 1672 | 425 |
Nm | ER+ | AE | < 0.0001 | 1.42 | 1.31 - 1.54 | 1897 | 624 |
N+ | ERm | MR | < 0.0001 | 1.56 | 1.36 - 1.80 | 439 | 166 |
N+ | ER+ | MR | < 0.0001 | 1.63 | 1.38 - 1.92 | 343 | 118 |
N- | ERm | AE | < 0.0001 | 1.38 | 1.23 - 1.55 | 1048 | 299 |
N- | ER+ | AE | < 0.0001 | 1.5 | 1.29 - 1.75 | 743 | 213 |
N+ | ERm | AE | < 0.0001 | 1.29 | 1.17 - 1.43 | 911 | 406 |
N- | ER+ | MR | < 0.0001 | 1.78 | 1.41 - 2.27 | 422 | 78 |
N+ | ER+ | AE | < 0.0001 | 1.33 | 1.18 - 1.51 | 685 | 284 |
N- | ERm | MR | 0.0001 | 1.42 | 1.20 - 1.69 | 590 | 111 |
Nm | ER- | MR | 0.0681 | 1.17 | 0.99 - 1.38 | 454 | 140 |
Nm | ER- | AE | 0.0878 | 1.12 | 0.98 - 1.27 | 727 | 278 |
N- | ER- | AE | 0.0909 | 1.23 | 0.97 - 1.56 | 285 | 82 |
N+ | ER- | MR | 0.3033 | 1.16 | 0.87 - 1.55 | 94 | 48 |
N- | ER- | MR | 0.7622 | 1.06 | 0.74 - 1.51 | 153 | 32 |
N+ | ER- | AE | 0.7638 | 1.03 | 0.84 - 1.27 | 223 | 122 |
Node or ER status (+: positive, −: negative, m: mixed); AE: any event; MR: metastatic relapse; HR: hazards ratio.